Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ledipasvir (Harvoni) (1 trial)
sofosbuvir (sovaldi) (1 trial)
dextrose (1 trial)
vitamin c (1 trial)
cefazolin (ancef) (1 trial)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Sepsis (Phase 2)
Toxemia (Phase 2)
Trials (3 total)
Trial APIs (5 total)